BackCytokinetics Overview

Cytokinetics Receivables

Track Cytokinetics's receivables ($24M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$24.43M
190.51% YoYΔ $16.02M vs prior year quarter

Peer trimmed avg / median

Loading

Cytokinetics Receivables History

Loading

Cytokinetics vs. peers: Receivables Comparison

Loading

Cytokinetics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cytokinetics (CYTK) FAQ

As of the most recent data (June 2026), CYTK shows a receivables of $24M. That compares with $8.4M in the prior-year period — up 190.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTK's receivables is now $24M (was $8.4M) — a 190.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cytokinetics is outperforming or lagging.

Tracking CYTK's receivables over time shows whether Cytokinetics is scaling, shrinking, or reshaping that part of the business. The current reading is $24M That compares with $8.4M in the prior-year period — up 190.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Cytokinetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $24M) with ownership activity and broader fundamentals.

Cytokinetics's receivables is $24M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.